RxDoctor Payments DataLook up a doctor →

Michele Degregorio, MD

Cardiovascular Disease · Bloomfield Hills, MINPI 1306808175

Payments from drug & device makers

$153,480in general payments, 2019–2025

Across 1,724 payments — averaging $89.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$44K
  • Lexicon Pharmaceuticals, Inc.$31K
  • Boehringer Ingelheim$27K
  • AstraZeneca$10K
  • Endologix LLC$8K
  • Medtronic$6K
  • plus $28K from 54 others
$135in research payments, 2019–2025

Across 1 payment — averaging $134.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$135

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC11$43,545
Lexicon Pharmaceuticals, Inc.50$31,265
Boehringer Ingelheim63$26,625
AstraZeneca91$9,729
Endologix LLC191$7,858
Medtronic(2 entities)209$6,431
Lilly USA, LLC4$3,438
Abbott105$3,325
Bayer15$2,029
Johnson & Johnson151$1,884
E.r. Squibb & Sons, L.L.C.109$1,791
Novartis98$1,712
Edwards Lifesciences9$1,120
Merck59$1,010
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)59$958
Boston Scientific15$938
Sanofi-aventis U.S. LLC51$916
Shockwave Medical, Inc16$760
Kestra Medical Technology Services, Inc.18$748
Esperion Therapeutics, Inc.46$741
Amarin Pharma, Inc.42$625
Pfizer38$619
Alnylam Pharmaceuticals Inc.50$533
Amgen37$526
Inari Medical, Inc.9$372
Novo Nordisk14$307
Cordis US CORP.2$268
Kiniksa Pharmaceuticals, Ltd.13$248
Biotronik Inc.5$244
Cardiovascular Systems Inc.19$224
Actelion Pharmaceuticals US, Inc.6$223
Regeneron Healthcare Solutions, Inc.15$200
Teleflex LLC2$158
Kowa Pharmaceuticals America, Inc.12$157
United Therapeutics Corporation6$139
Cagent Vascular Inc2$128
Abiomed4$115
Daiichi Sankyo Inc.6$110
Chiesi USA, Inc.6$104
Imperative Care, Inc3$100
Heartflow, Inc.5$100
W. L. Gore & Associates, Inc.3$92
Scpharmaceuticals Inc.5$79
Kiniksa Pharmaceuticals International, PLC4$79
Cook Medical LLC4$74
Baxter Healthcare1$73
Angiodynamics, Inc.3$70
Reflow Medical Inc2$60
Cardinal Health 200 LLC3$55
Penumbra, Inc.4$55
Astellas Pharma US Inc3$54
Cvrx, Inc.3$52
Inspire Medical Systems, Inc.1$44
Lundbeck LLC3$38
Cleerly, Inc.1$30
Truvic Medical, Inc.2$29
Cardiva Medical, Inc.1$29
Arbor Pharmaceuticals, Inc.2$26
Bard Peripheral Vascular, Inc.1$23
Irhythm Technologies, Inc.1$23

How this compares

$153,480 in reported general payments places this provider in the 90th percentile of 760 cardiovascular disease providers in Michigan.

See all cardiovascular disease providers in Michigan →

Medicare billing

Part B allowed, 2024
$909,153
Medicare patients
2,043
Services billed
11,078

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Bloomfield Hills

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →